Acute bronchitis due to other specified organisms
ICD-10 J20.8 is a billable code used to indicate a diagnosis of acute bronchitis due to other specified organisms.
Acute bronchitis due to other specified organisms is characterized by inflammation of the bronchial tubes, leading to cough, sputum production, and difficulty breathing. The condition typically arises following a viral infection, but in this case, it is attributed to specific non-viral pathogens such as bacteria or atypical organisms. The anatomy involved includes the bronchi, which are the major air passages from the trachea to the lungs. Disease progression may vary; while many patients recover within a few weeks, some may experience prolonged symptoms or complications, particularly if there are underlying respiratory conditions. Diagnostic considerations include a thorough clinical history, physical examination, and possibly imaging or sputum cultures to identify the causative organism. It is crucial to differentiate J20.8 from other types of bronchitis, such as J20.0 (acute bronchitis due to viral infection) and J40 (bronchitis, not specified as acute or chronic), to ensure appropriate management and treatment.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
J20.8 covers acute bronchitis caused by specified organisms other than the common viral pathogens. This may include bacterial infections or atypical pathogens such as Mycoplasma pneumoniae or Chlamydia pneumoniae, which require specific diagnostic criteria for identification.
J20.8 should be used when the acute bronchitis is confirmed to be due to a specified organism that is not classified under other codes, such as J20.0 for viral causes. Proper laboratory confirmation or clinical evidence of the specific organism is essential for accurate coding.
Documentation should include a clear clinical history, physical examination findings, laboratory results identifying the specific organism, and treatment plans. Detailed notes on the patient's symptoms and response to treatment are also critical to support the use of J20.8.
